US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Risk Class IClass IIClass III
Status OngoingCompletedTerminated
Year 2026202520242023
Class II · Moderate risk Terminated

Revonto

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 78670-003-67 D-1081-2022
Class II · Moderate risk Terminated

Revonto

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 27505-003-67 D-1080-2022
Class II · Moderate risk Terminated

Vecuronium Bromide for Injection

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0703-2914-03 D-1079-2022
Class II · Moderate risk Terminated

Propofol Injectable Emulsion

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-2136-95 D-1078-2022
Class II · Moderate risk Terminated

Propofol Injectable Emulsion

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 00591-2136-51 D-1077-2022
Class II · Moderate risk Terminated

Proair

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 59310-579-22 D-1076-2022
Class II · Moderate risk Terminated

Mupirocin Ointment

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0093-1010-42 D-1075-2022
Class II · Moderate risk Terminated

Lidocaine Patch 5%

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0591-3525-30 D-1068-2022
Class II · Moderate risk Terminated

Clonidine Hydrochloride Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 00228-2127-10 D-1066-2022
Class II · Moderate risk Terminated

Ketoconazole Cream

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0168-0099-60 D-1065-2022
Class II · Moderate risk Terminated

Sulfamethoxazole and Trimethoprim Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-2725-61 D-1059-2022
Class II · Moderate risk Terminated

Sodium Bicarbonate Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0536-1047-10 D-1058-2022
Class II · Moderate risk Terminated

Promethazine HCl Tablets

Reason cGMP deviations: Temperature abuse

Mckesson Medical-Surgical Inc. Corporate Office NDC 0904-6461-61 D-1057-2022